SUMOylated PABPC1 Shields Mitophagy Genes Inside Stress Granules to Help Cells Survive
A newly discovered PABPC1 modification locks protective mitophagy mRNAs inside stress granules, boosting cancer cell survival under stress.
Summary
When cells face stress — from heat, toxins, or nutrient deprivation — they form protective droplets called stress granules (SGs). Researchers discovered that a protein called PABPC1 gets chemically tagged (SUMOylated) during stress, which drives SG formation and selectively shields a specific class of mRNAs with U-rich sequences from degradation. These protected mRNAs code for mitophagy proteins FUNDC1 and BNIP3L, which clear out damaged mitochondria. By partnering with RNA-binding protein TIA1 via a SUMO-interaction motif, SUMOylated PABPC1 forms a protective complex inside SGs. This mechanism preserves mitochondrial quality, maintains cellular homeostasis, and — in cancer cells — enhances survival under chemotherapy and other stressors.
Detailed Summary
Cells under stress rapidly assemble membraneless cytoplasmic compartments called stress granules (SGs), which regulate mRNA fate and help cells survive hostile conditions. While SGs are known to sequester select mRNAs, the molecular logic governing which transcripts are protected — and why — has remained poorly understood. This Nature Communications study identifies a specific post-translational modification on PABPC1, a core SG scaffold protein, as the key sorting signal that links stress sensing to selective mRNA protection and mitophagy activation.
The authors demonstrate that PABPC1 undergoes robust SUMOylation — predominantly via SUMO1 — upon exposure to sodium arsenite (oxidative stress), heat shock, sorbitol (osmotic stress), and glucose starvation. SUMOylation peaked within 1–3 hours of arsenite treatment and resolved upon stress removal, precisely tracking SG assembly and disassembly as confirmed by co-immunofluorescence with SG marker G3BP1. The modification was validated through multiple orthogonal methods: Ni2+-NTA pulldown, denaturing immunoprecipitation in SENP1-knockout cells, and a prokaryotic in vitro SUMOylation assay in E. coli expressing GST-PABPC1 with the pT-E1E2S1 plasmid.
Using site-directed mutagenesis, the team mapped the primary SUMOylation site to lysine 512 (K512), which lies within the RNA recognition motif (RRM3) domain of PABPC1. A K512R substitution abolished SUMOylation, impaired SG formation, and dramatically reduced cancer cell viability under stress. Conversely, a phosphomimetic SUMO-fused PABPC1 construct rescued these deficits. Transcriptome-wide RNA sequencing and eCLIP-seq revealed that SUMOylated PABPC1 preferentially stabilizes mRNAs containing conserved U-rich elements (UREs) in their 3' UTRs — a distinct selectivity not shared by unmodified PABPC1.
Mechanistically, SUMOylated PABPC1 was found to directly interact with TIA1 via TIA1's SUMO-interacting motif (SIM). This PABPC1–SUMO–TIA1 ternary complex recruits U-rich mRNAs into SGs, protecting them from exosome-mediated degradation. Among the most prominently stabilized transcripts were FUNDC1 and BNIP3L, two critical receptors for mitophagy — the selective autophagic removal of damaged mitochondria. Blocking K512 SUMOylation reduced FUNDC1 and BNIP3L protein expression, impaired mitophagy flux (measured by LC3-II puncta, mitochondrial mass markers, and COX IV levels), and increased mitochondrial reactive oxygen species accumulation, ultimately sensitizing cells to stress-induced death.
Functionally, cancer cell lines with restored SUMOylated PABPC1 showed significantly enhanced survival under arsenite, chemotherapy, and nutrient deprivation conditions, while PABPC1-K512R-expressing cells exhibited markedly reduced clonogenic survival. These findings establish a direct molecular chain from stress sensing → PABPC1 K512 SUMOylation → SG-mediated U-rich mRNA stabilization → mitophagy gene upregulation → cellular homeostasis and survival. The study positions PABPC1 SUMOylation as a potential therapeutic vulnerability in cancers that rely on stress adaptation for chemoresistance, and more broadly illuminates how cells prioritize specific survival transcripts during stress.
Key Findings
- PABPC1 undergoes SUMO1 modification peaking within 1–3 hours of oxidative stress (sodium arsenite), heat shock, osmotic stress, and glucose starvation, with SUMOylation levels dynamically reversing upon stress removal.
- Lysine 512 (K512) within the RRM3 domain was identified as the primary SUMO1 conjugation site; K512R mutation abolished SUMOylation, impaired stress granule assembly, and reduced cancer cell survival under stress.
- Transcriptome-wide eCLIP-seq and RNA-seq showed SUMOylated PABPC1 selectively stabilizes mRNAs bearing conserved U-rich elements (UREs) in their 3' UTRs, a selectivity absent in unmodified PABPC1.
- SUMOylated PABPC1 forms a ternary PABPC1–SUMO–TIA1 complex via TIA1's SUMO-interacting motif (SIM), recruiting U-rich mRNAs into stress granules and shielding them from degradation.
- Mitophagy receptor genes FUNDC1 and BNIP3L — both bearing U-rich 3' UTR elements — were among the most prominently stabilized transcripts; their protein levels dropped significantly in K512R-mutant cells.
- Loss of K512 SUMOylation impaired mitophagy flux (reduced LC3-II puncta and altered mitochondrial mass markers), increased mitochondrial ROS, and markedly reduced clonogenic cancer cell survival under multiple stress conditions.
- SENP1 knockout (which elevates global SUMOylation) confirmed endogenous PABPC1 SUMOylation and enhanced SG formation, while SENP1 overexpression dissolved SGs and sensitized cells to stress-induced death.
Methodology
The study used HEK-293T and H1299 lung cancer cell lines with CRISPR-Cas9 knockouts, transient transfection of tagged constructs, and multiple SUMOylation validation methods (Ni2+-NTA pulldown, denaturing IP, prokaryotic GST-pulldown). Transcriptome-wide mRNA stabilization was profiled via eCLIP-seq and RNA-seq; mitophagy flux was measured using LC3-II puncta, mitochondrial mass markers (COX IV, TOMM20), and mitochondrial ROS assays. Stress conditions included sodium arsenite (0.5 mM), heat shock, sorbitol, and glucose deprivation, with recovery time-courses to track dynamic SUMOylation. No randomization or blinding procedures were explicitly described, and all experiments were performed in cell-based systems without in vivo animal models.
Study Limitations
This study was conducted entirely in cell lines (HEK-293T and H1299), with no in vivo animal or human data presented, limiting translational confidence. The quantitative effect sizes (fold-changes, p-values) from RNA-seq and survival assays are not numerically specified in the abstract or methods summary provided, making independent replication assessment difficult. The authors do not explicitly discuss potential off-target effects of CRISPR knockouts or the physiological relevance of the specific stress doses used (e.g., 0.5 mM arsenite), which may not fully recapitulate clinical stress conditions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
